Investors
Board and leadership
Key to committees/roles:
Non-executive Chairman
Background/current external appointments: Peter Allen has served as a member of our board since June 2018. Mr. Allen is also currently Non-Executive Chairman of Advanced Medical Solutions plc. He is a Non-Executive Director of Istesso Ltd. Mr. Allen has nearly 30 years’ experience as an executive director, non-executive director and chairman in a wide range of life science companies. From 2012 to 2021, Mr. Allen served as the Chairman of Clinigen plc. From 2011 to 2022, Mr. Allen served as a non-executive director and then the Chairman of Oxford Nanopore Technologies plc. From 2015 to 2020, Mr. Allen served as the Chairman of Diurnal Group plc. From 2009 to 2012, Mr. Allen served as Chairman of Proximagen Neurosciences plc, from 2005 to 2013 he served as Chairman of ProStrakan Group plc, including as interim CEO from 2010 to 2011, and he served as CFO and Deputy CEO of Celltech Group plc from 1992 to 2004. Mr. Allen holds a BA in Accountancy and Law from the University of Kent.
Skills, experience and contribution: A chartered accountant by background, Peter brings to Abcam his experience as a chairman and board member and has substantial experience in M&A, international growth, fundraising and investor relations, as well as the commercialisation of intellectual property.